Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia ...

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has been given an average recommendation of “Buy” by the seven analysts that are currently covering the company, Marketbeat reports.

BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording ...

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and ...

Get Our Latest Research Report on ZURA Zura Bio Stock Performance Shares of NASDAQ ZURA opened at $1.19 on Tuesday. Zura Bio Limited has a 52-week low of $1.10 and a 52-week high of $6.35. The ...